• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONVATEC DOMINICAN REPUBLIC INC AQUACEL AG+/AAA SURGICAL; DRESSING, WOUND, DRUG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONVATEC DOMINICAN REPUBLIC INC AQUACEL AG+/AAA SURGICAL; DRESSING, WOUND, DRUG Back to Search Results
Model Number 422606
Medical Device Problem Codes Delivered as Unsterile Product (1421); Unsealed Device Packaging (1444); Packaging Problem (3007)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Event or Problem Description
The emdr is being submitted for five company¿s dressings from one market unit with unsealed packaging causing the product to fall out of the secondary packaging.It was reported by a representative from surgical suite to the company¿s sales representative that when they went to use the dressing, after opening the package from the end with the arrow, the dressing fell out from the opposite end due to the packaging not being heat sealed properly at the other end.The product was not used on patient.The photographs depicting the issue were obtained by company¿s sales representative and sent to company's product manager.
 
Additional Manufacturer Narrative
Device 1 of 5.Common device name: dressing, wound, drug.Name of the affiliation: (b)(6).Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: (b)(4).Manufacturing site: (b)(4).
 
Event or Problem Description
To date no additional patient or event details have been received.
 
Additional Manufacturer Narrative
Additional information - this emdr is being submitted to include the below: h6 - investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions h10: investigation summary d17 is selected under imdrf cause conclusion because the concluded cause is not adequately described by any other term for the machine not having a method for avoid performing the operation on out of the validated process ranges for temperature batch record review: lot 2g00896 was manufactured on 07/18/2022, in the surgical cover dressing (scd) line with a total of (b)(4) market units.Complaint investigator performed a batch record review on 03/10/2023, to verify if all the applicable procedures were followed system application product (sap) material identification 1728533 and manufacturing order (b)(4).As result no nonconformance was identified.Photo related to the reported problem is available for evaluation.Investigation conclusion: the purpose of this root cause investigation is the identify the probable cause for the complaint generated for surgical cover dressing (scd) 3 line due to ¿open seal (malfunction) scd¿.During the batch record review process for affected lot 2g00895 manufactured in surgical cover dressing (scd), order no.(b)(4) and system application product (sap) code 1728501, it was identified that these batches had no deviations, nonconformities, corrections, or corrective/preventative action (capa) within the quality system (database).The applicable quality tests performed to these batches based on the process instructions (pi) for assembly and primary packaging - surgical cover dressing, obtained satisfactory results.All the components for assembly were correct per bill of materials (bom) and the machine parameters documented were also correct and documented in ¿anexo 1¿ of procedure instruction (pi).In addition, dimensional and seal test were performed with satisfactory results and documented in anexo 2 of procedure instruction (pi).No irregularities were found related to malfunction, nevertheless, as resulted on the section c) and d) is the probable cause of the issue since the equipment has no enabled alarms or others prevention systems for avoiding running the equipment with the validated parameters out of the process specification ranges as per procedure instruction (pi).-root cause (s).Method: the machine does not have a method for avoid performing the operation on out of the validated process ranges for temperature.This issue will be monitored through the post market product monitoring review process.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 9618003.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUACEL AG+/AAA SURGICAL
Common Device Name
DRESSING, WOUND, DRUG
Manufacturer (Section D)
CONVATEC DOMINICAN REPUBLIC INC
km 18.5 parque industrial
itabo, s.a. haina
san cristobal 91000
DR  91000
Manufacturer (Section G)
CONVATEC DOMINICAN REPUBLIC INC
km 18.5 parque industrial
itabo, s.a. haina
san cristobal 91000
DR   91000
Manufacturer Contact
pamela meadows
7815 national service road
suite 600
greensboro, NC 
3365424679
MDR Report Key16270216
Report Number9618003-2023-00123
Device Sequence Number17662995
Product Code FRO
UDI-Device Identifier00768455169559
UDI-Public00768455169559
Combination Product (Y/N)N
PMA/510(K) Number
K091034
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 01/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date07/01/2024
Device Model Number422606
Device Catalogue Number422606
Device Lot Number2G00896
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/18/2023
Was the Report Sent to FDA? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/06/2023
Supplement Date Received by Manufacturer03/13/2023
Initial Report FDA Received Date01/31/2023
Supplement Report FDA Received Date04/05/2023
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/18/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-